HOBOKEN, NJ — Quantum Computing Inc. (QCi), a leader in integrated photonics and quantum optics technology, has announced an exciting new collaboration with the Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. (Sanders TDI) to advance research in computational biomedicine. This partnership will leverage QCi’s cutting-edge quantum computation technology, particularly its Dirac-3 Entropy Quantum Computing Machine, to support Sanders TDI’s work in experimental drug discovery.

Based in New York City, Sanders TDI is a non-profit drug discovery institute comprising Kettering Cancer Center, The Rockefeller University, and Memorial Sloan Weill Cornell Medicine. The Institute is dedicated to advancing groundbreaking biological discoveries, focusing on preclinical studies aimed at preventing the initiation and progression of diseases. Sanders TDI also offers industrial-scale technical support to academic research and projects in the field.

Through this collaboration, QCi will provide Sanders TDI with cloud-based access to its Dirac-3 quantum systems, which operate at room temperature and require minimal power. These systems are specifically designed to solve complex optimization problems, making them an ideal tool for enhancing Sanders TDI’s research efforts.

“We are thrilled to collaborate with Sanders TDI and contribute to their groundbreaking work in assessing targeted therapeutics for human diseases,” said Dr. William McGann, CEO of QCi. “This partnership demonstrates how our quantum machines can deliver actionable insights and analyses today. It aligns with our mission to make quantum technology accessible and affordable, showcasing its real-world potential in solving critical problems.”

The collaboration will focus on advancing Sanders TDI’s computational chemistry research by applying quantum technologies, including quantum analog computers, to biomolecular modeling. QCi will work closely with Sanders TDI to explore various quantum-enabled applications, aiming to identify the most impactful use cases for their Dirac systems.

For more information about QCi’s advancements in accessible photonic technology and collaboration opportunities, visit the QCi website.